Medirom Healthcare [MRM] vs Medifast [MED] Detailed Stock Comparison
Medirom Healthcare
NASDAQ
Loading...
Medifast
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Medirom Healthcare wins in 8 metrics, Medifast wins in 8 metrics, with 0 ties. Both stocks appear equally matched on key metrics.
View Metrics Details
Vital Metrics Comparison
| Metric | Medirom Healthcare | Medifast | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 9.47 | 42.88 | Medirom Healthcare |
| Price-to-Book Ratio | 0.02 | 0.67 | Medirom Healthcare |
| Debt-to-Equity Ratio | 400.54 | 6.05 | Medifast |
| PEG Ratio | N/A | -0.33 | N/A |
| EV/EBITDA | 12.54 | -0.16 | Medifast |
| Profit Margin (TTM) | 1.79% | 0.76% | Medirom Healthcare |
| Operating Margin (TTM) | 13.30% | -1.01% | Medirom Healthcare |
| EBITDA Margin (TTM) | 13.30% | N/A | N/A |
| Return on Equity | 22.96% | 1.73% | Medirom Healthcare |
| Return on Assets (TTM) | 0.04% | 2.88% | Medifast |
| Free Cash Flow (TTM) | $-12.84M | $17.02M | Medifast |
| 1-Year Return | -69.74% | -29.18% | Medifast |
| Price-to-Sales Ratio (TTM) | 0.00 | 0.32 | Medirom Healthcare |
| Enterprise Value | $25.02M | $-4.30M | Medirom Healthcare |
| EV/Revenue Ratio | 0.45 | -0.01 | Medifast |
| Gross Profit Margin (TTM) | N/A | 72.61% | N/A |
| Revenue per Share (TTM) | $1,625 | $44 | Medirom Healthcare |
| Earnings per Share (Diluted) | $0.19 | $0.33 | Medifast |
| Beta (Stock Volatility) | 0.88 | 0.82 | Medifast |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Medirom Healthcare vs Medifast Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Medirom Healthcare | 1.67% | -17.81% | 30.43% | 127.85% | 104.55% | 78.22% |
| Medifast | -3.43% | 7.28% | 2.61% | 1.00% | -0.98% | -18.16% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Medirom Healthcare | -69.74% | -73.66% | -87.71% | -87.71% | -87.71% | -87.71% |
| Medifast | -29.18% | -89.47% | -91.51% | -49.46% | -49.59% | 243.45% |
Performance & Financial Health Analysis: Medirom Healthcare vs Medifast
| Metric | MRM | MED |
|---|---|---|
| Market Information | ||
| Market Cap | $14.22M | $155.52M |
| Market Cap Category | Micro cap | Micro cap |
| 10 Day Avg. Volume | 13,755,920 | 198,340 |
| 90 Day Avg. Volume | 4,601,657 | 211,303 |
| Last Close | $1.83 | $13.66 |
| 52 Week Range | $0.34 - $8.39 | $11.57 - $21.98 |
| % from 52W High | -78.19% | -37.83% |
| All-Time High | $19.80 (Dec 28, 2020) | $336.99 (May 24, 2021) |
| % from All-Time High | -90.76% | -95.95% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.31% | -0.37% |
| Quarterly Earnings Growth | 0.55% | -0.37% |
| Financial Health | ||
| Profit Margin (TTM) | 0.02% | 0.01% |
| Operating Margin (TTM) | 0.13% | -0.01% |
| Return on Equity (TTM) | 0.23% | 0.02% |
| Debt to Equity (MRQ) | 400.54 | 6.05 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $118.11 | $21.04 |
| Cash per Share (MRQ) | $41.69 | $15.84 |
| Operating Cash Flow (TTM) | $-9,014,839 | $4.15M |
| Levered Free Cash Flow (TTM) | $-7,095,987 | $10.69M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | $0.00 |
Valuation & Enterprise Metrics Analysis: Medirom Healthcare vs Medifast
| Metric | MRM | MED |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 9.47 | 42.88 |
| Forward P/E | N/A | 47.17 |
| PEG Ratio | N/A | -0.33 |
| Price to Sales (TTM) | 0.00 | 0.32 |
| Price to Book (MRQ) | 0.02 | 0.67 |
| Market Capitalization | ||
| Market Capitalization | $14.22M | $155.52M |
| Enterprise Value | $25.02M | $-4,297,744 |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.45 | -0.01 |
| Enterprise to EBITDA | 12.54 | -0.16 |
| Risk & Other Metrics | ||
| Beta | 0.88 | 0.82 |
| Book Value per Share (MRQ) | $118.11 | $21.04 |
Financial Statements Comparison: Medirom Healthcare vs Medifast
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | MRM | MED |
|---|---|---|
| Revenue/Sales | N/A | $115.73M |
| Cost of Goods Sold | N/A | $31.48M |
| Gross Profit | N/A | $84.25M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | N/A | $-1.26M |
| EBITDA | N/A | $2.02M |
| Pre-Tax Income | N/A | $526,000 |
| Income Tax | N/A | $1.30M |
| Net Income (Profit) | N/A | $-772,000 |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | MRM | MED |
|---|---|---|
| Cash & Equivalents | $2.23M | $91.72M |
| Total Current Assets | $18.33M | $213.52M |
| Total Current Liabilities | $28.32M | $60.60M |
| Long-Term Debt | $13.90M | $8.45M |
| Total Shareholders Equity | $8.05M | $210.96M |
| Retained Earnings | $1.55M | $176.01M |
| Property, Plant & Equipment | $14.04M | $46.32M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | MRM | MED |
|---|---|---|
| Operating Cash Flow | N/A | $2.62M |
| Capital Expenditures | N/A | $-1.52M |
| Free Cash Flow | N/A | $1.88M |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | $-369,000 |
Short Interest & Institutional Ownership Analysis
| Metric | MRM | MED |
|---|---|---|
| Shares Short | 3,836 | 2.29M |
| Short Ratio | 0.17 | 11.35 |
| Short % of Float | 0.00% | 0.21% |
| Average Daily Volume (10 Day) | 13,755,920 | 198,340 |
| Average Daily Volume (90 Day) | 4,601,657 | 211,303 |
| Shares Outstanding | 53,492 | 10.94M |
| Float Shares | 5.81M | 9.15M |
| % Held by Insiders | 0.26% | 0.03% |
| % Held by Institutions | 0.03% | 0.80% |
Dividend Analysis & Yield Comparison: Medirom Healthcare vs Medifast
| Metric | MRM | MED |
|---|---|---|
| Last 12-Month Dividend | N/A | $0.00 |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | $2.74 |
| 3-Year Avg Dividend Yield | N/A | 1.43% |
| 3-Year Total Dividends | N/A | $8.22 |
| Ex-Dividend Date | N/A | Jun 26, 2023 |